These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12661796)

  • 21. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atosiban for prophylactic tocolysis following transabdominal cervico-isthmic cerclage.
    Bollapragada SS; McLellan D; Anthony GS
    J Obstet Gynaecol; 2006 Jul; 26(5):462-3. PubMed ID: 16846879
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience.
    Al-Riyami N; Al-Badri H; Jaju S; Pillai S
    Sultan Qaboos Univ Med J; 2021 May; 21(2):e260-e265. PubMed ID: 34221474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atosiban and nifedipine in acute tocolysis: a comparative study.
    Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the efficacy of atosiban in pregnant women with threatened preterm labor associated with assisted reproductive technology.
    Xu YJ; Ran LM; Zhai SS; Luo XH; Zhang YY; Zhou ZY; Liu YH; Ren LD; Hong T; Liu R
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1881-7. PubMed ID: 27212183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.
    Coomarasamy A; Knox EM; Gee H; Song F; Khan KS
    BJOG; 2003 Dec; 110(12):1045-9. PubMed ID: 14664874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current medical therapy in the prevention and treatment of preterm labour.
    Tara PN; Thornton S
    Semin Fetal Neonatal Med; 2004 Dec; 9(6):481-9. PubMed ID: 15691786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atosiban.
    Shubert PJ
    Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The threat of premature labor: new aspects for management].
    Wertz JP; Frising M; Arendt J
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):51-8. PubMed ID: 9868833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
    Wex J; Abou-Setta AM; Clerici G; Di Renzo GC
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):128-35. PubMed ID: 21620558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and clinical experience with the new evidence-based tocolytic atosiban.
    Husslein P
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):633-41. PubMed ID: 12190838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developments in the pharmacotherapeutic management of spontaneous preterm labor.
    Kam KY; Lamont RF
    Expert Opin Pharmacother; 2008 May; 9(7):1153-68. PubMed ID: 18422473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine.
    Neri I; Monari F; Valensise H; Vasapollo B; Facchinetti F; Volpe A
    Am J Perinatol; 2009 Apr; 26(4):259-63. PubMed ID: 19021095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging issues over the choice of nifedipine, beta-agonists and atosiban for tocolysis in spontaneous preterm labour--a proposed systematic review by the International Preterm Labour Council.
    Beattie RB; Helmer H; Khan KS; Lamont RF; McNamara H; Svare J; Tsatsaris V; van Geijn HP;
    J Obstet Gynaecol; 2004 Apr; 24(3):213-5. PubMed ID: 15203610
    [No Abstract]   [Full Text] [Related]  

  • 37. Atosiban and nifedipin for the treatment of preterm labor.
    Kashanian M; Akbarian AR; Soltanzadeh M
    Int J Gynaecol Obstet; 2005 Oct; 91(1):10-4. PubMed ID: 16043178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
    Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.
    Nisell H; Wolff K
    BJOG; 2003 Jan; 110(1):89. PubMed ID: 12504956
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model].
    Hrubý K
    Ceska Gynekol; 2004 Mar; 69(2):96-105. PubMed ID: 15141520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.